Amgen (AMGN) Tops Q4 EPS by 27c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $393.17 -10.08%
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.31, $0.27 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.1 billion versus the consensus estimate of $8.85 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.82.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Goldgroup Mining launches $75M private placement with $60M committed
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
